Loading…
Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway
The underlying mechanism of gemcitabine resistance during breast cancer treatment remains unclear. Glucose regulated protein 78 (GRP78) frequently triggered by anticancer agents, was substantially elevated in gemcitabine resistant sublines. Ectopic expression of GRP78 changes gemcitabine chemosensit...
Saved in:
Published in: | Biochemical and biophysical research communications 2016-06, Vol.474 (3), p.612-619 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c356t-701122c72fb212e6aa273e30d4914e10d369df6cd7ba7631909e08a57cb28b393 |
---|---|
cites | cdi_FETCH-LOGICAL-c356t-701122c72fb212e6aa273e30d4914e10d369df6cd7ba7631909e08a57cb28b393 |
container_end_page | 619 |
container_issue | 3 |
container_start_page | 612 |
container_title | Biochemical and biophysical research communications |
container_volume | 474 |
creator | Xie, Jie Tao, Zhong-Hua Zhao, Jiang Li, Ting Wu, Zheng-Hua Zhang, Jin-Feng Zhang, Jian Hu, Xi-Chun |
description | The underlying mechanism of gemcitabine resistance during breast cancer treatment remains unclear. Glucose regulated protein 78 (GRP78) frequently triggered by anticancer agents, was substantially elevated in gemcitabine resistant sublines. Ectopic expression of GRP78 changes gemcitabine chemosensitivity and apoptosis levels in breast cancer cells. Further experiments showed an involvement of caspase 9, not caspase 8, in gemcitabine resistance and GRP78-mediated chemosensitivity, suggesting that mitochondria apoptotic pathway was activated by GRP78. This finding was further supported by the observations of AKT activation, Bcl-2 increase, Bax and Bim decrease. Conclusively, GRP78 plays a vital role in gemcitabine resistance and clinical strategy to improve gemcitabine efficacy in breast cancer by manipulating GRP78 should be explored.
•GRP78 change gemcitabine chemosensitivity and apoptosis by activating Akt/mitochondria apoptotic pathway.•Ectopic expressions of GRP78 change gemcitabine chemosensitivity and apoptosis.•Akt/mitochondria apoptotic pathway, rather than ER stress-induced ER-Ca2+-caspase 8 pathway was activated by GRP78. |
doi_str_mv | 10.1016/j.bbrc.2016.03.002 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1790461653</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X16303151</els_id><sourcerecordid>1790461653</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-701122c72fb212e6aa273e30d4914e10d369df6cd7ba7631909e08a57cb28b393</originalsourceid><addsrcrecordid>eNp9kcGO0zAQhi0EYsvCC3BAPi6HZMdOmjQSl9UKCmIlEFokbpZjT7ZTJXaxnaK-0D7numrhyGnm8M8388_P2FsBpQDRXG_Lvg-mlLkvoSoB5DO2ENBBIQXUz9kCAJpCduLXBXsV4xZAiLrpXrIL2YKQEroFe1yPs_ERecCHedQJLd8Fn5Acb1f8av3je7t6z8ltqKcUud75XfKRcucs1ymhS-TmhJGbDU4Z5CIl2lM6cD_wB5wMJd2Tw8zgfUAdEzfaGQzc4DjyPWl-8_X-eqLkzcY7G0iP5zWJDN_ptPmjD6_Zi0GPEd-c6yX7-enj_e3n4u7b-svtzV1hqmWTimwr-zKtHHopJDZay7bCCmzdiRoF2Krp7NAY2_a6bSrRQYew0svW9HLVV111ya5O3PyE3zPGpCaKx0O1Qz9HJdoO6kY0yypL5Ulqgo8x4KB2gSYdDkqAOuajtuqYjzrmo6BSOZ889O7Mn_sJ7b-Rv4FkwYeTALPLPWFQ0RDmf1kKaJKynv7HfwIW6aPT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1790461653</pqid></control><display><type>article</type><title>Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway</title><source>ScienceDirect Journals</source><creator>Xie, Jie ; Tao, Zhong-Hua ; Zhao, Jiang ; Li, Ting ; Wu, Zheng-Hua ; Zhang, Jin-Feng ; Zhang, Jian ; Hu, Xi-Chun</creator><creatorcontrib>Xie, Jie ; Tao, Zhong-Hua ; Zhao, Jiang ; Li, Ting ; Wu, Zheng-Hua ; Zhang, Jin-Feng ; Zhang, Jian ; Hu, Xi-Chun</creatorcontrib><description>The underlying mechanism of gemcitabine resistance during breast cancer treatment remains unclear. Glucose regulated protein 78 (GRP78) frequently triggered by anticancer agents, was substantially elevated in gemcitabine resistant sublines. Ectopic expression of GRP78 changes gemcitabine chemosensitivity and apoptosis levels in breast cancer cells. Further experiments showed an involvement of caspase 9, not caspase 8, in gemcitabine resistance and GRP78-mediated chemosensitivity, suggesting that mitochondria apoptotic pathway was activated by GRP78. This finding was further supported by the observations of AKT activation, Bcl-2 increase, Bax and Bim decrease. Conclusively, GRP78 plays a vital role in gemcitabine resistance and clinical strategy to improve gemcitabine efficacy in breast cancer by manipulating GRP78 should be explored.
•GRP78 change gemcitabine chemosensitivity and apoptosis by activating Akt/mitochondria apoptotic pathway.•Ectopic expressions of GRP78 change gemcitabine chemosensitivity and apoptosis.•Akt/mitochondria apoptotic pathway, rather than ER stress-induced ER-Ca2+-caspase 8 pathway was activated by GRP78.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2016.03.002</identifier><identifier>PMID: 27012209</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Antimetabolites, Antineoplastic - administration & dosage ; Apoptosis ; Breast cancer ; Breast Neoplasms - drug therapy ; Breast Neoplasms - metabolism ; Breast Neoplasms - pathology ; Deoxycytidine - administration & dosage ; Deoxycytidine - analogs & derivatives ; Dose-Response Relationship, Drug ; Gemcitabine resistance ; GRP78 ; Heat-Shock Proteins - metabolism ; Humans ; MCF-7 Cells ; Mitochondria - drug effects ; Mitochondria - metabolism ; Proto-Oncogene Proteins c-akt - metabolism ; Signal Transduction - drug effects</subject><ispartof>Biochemical and biophysical research communications, 2016-06, Vol.474 (3), p.612-619</ispartof><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-701122c72fb212e6aa273e30d4914e10d369df6cd7ba7631909e08a57cb28b393</citedby><cites>FETCH-LOGICAL-c356t-701122c72fb212e6aa273e30d4914e10d369df6cd7ba7631909e08a57cb28b393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27012209$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xie, Jie</creatorcontrib><creatorcontrib>Tao, Zhong-Hua</creatorcontrib><creatorcontrib>Zhao, Jiang</creatorcontrib><creatorcontrib>Li, Ting</creatorcontrib><creatorcontrib>Wu, Zheng-Hua</creatorcontrib><creatorcontrib>Zhang, Jin-Feng</creatorcontrib><creatorcontrib>Zhang, Jian</creatorcontrib><creatorcontrib>Hu, Xi-Chun</creatorcontrib><title>Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>The underlying mechanism of gemcitabine resistance during breast cancer treatment remains unclear. Glucose regulated protein 78 (GRP78) frequently triggered by anticancer agents, was substantially elevated in gemcitabine resistant sublines. Ectopic expression of GRP78 changes gemcitabine chemosensitivity and apoptosis levels in breast cancer cells. Further experiments showed an involvement of caspase 9, not caspase 8, in gemcitabine resistance and GRP78-mediated chemosensitivity, suggesting that mitochondria apoptotic pathway was activated by GRP78. This finding was further supported by the observations of AKT activation, Bcl-2 increase, Bax and Bim decrease. Conclusively, GRP78 plays a vital role in gemcitabine resistance and clinical strategy to improve gemcitabine efficacy in breast cancer by manipulating GRP78 should be explored.
•GRP78 change gemcitabine chemosensitivity and apoptosis by activating Akt/mitochondria apoptotic pathway.•Ectopic expressions of GRP78 change gemcitabine chemosensitivity and apoptosis.•Akt/mitochondria apoptotic pathway, rather than ER stress-induced ER-Ca2+-caspase 8 pathway was activated by GRP78.</description><subject>Antimetabolites, Antineoplastic - administration & dosage</subject><subject>Apoptosis</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Breast Neoplasms - metabolism</subject><subject>Breast Neoplasms - pathology</subject><subject>Deoxycytidine - administration & dosage</subject><subject>Deoxycytidine - analogs & derivatives</subject><subject>Dose-Response Relationship, Drug</subject><subject>Gemcitabine resistance</subject><subject>GRP78</subject><subject>Heat-Shock Proteins - metabolism</subject><subject>Humans</subject><subject>MCF-7 Cells</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - metabolism</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>Signal Transduction - drug effects</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kcGO0zAQhi0EYsvCC3BAPi6HZMdOmjQSl9UKCmIlEFokbpZjT7ZTJXaxnaK-0D7numrhyGnm8M8388_P2FsBpQDRXG_Lvg-mlLkvoSoB5DO2ENBBIQXUz9kCAJpCduLXBXsV4xZAiLrpXrIL2YKQEroFe1yPs_ERecCHedQJLd8Fn5Acb1f8av3je7t6z8ltqKcUud75XfKRcucs1ymhS-TmhJGbDU4Z5CIl2lM6cD_wB5wMJd2Tw8zgfUAdEzfaGQzc4DjyPWl-8_X-eqLkzcY7G0iP5zWJDN_ptPmjD6_Zi0GPEd-c6yX7-enj_e3n4u7b-svtzV1hqmWTimwr-zKtHHopJDZay7bCCmzdiRoF2Krp7NAY2_a6bSrRQYew0svW9HLVV111ya5O3PyE3zPGpCaKx0O1Qz9HJdoO6kY0yypL5Ulqgo8x4KB2gSYdDkqAOuajtuqYjzrmo6BSOZ889O7Mn_sJ7b-Rv4FkwYeTALPLPWFQ0RDmf1kKaJKynv7HfwIW6aPT</recordid><startdate>20160603</startdate><enddate>20160603</enddate><creator>Xie, Jie</creator><creator>Tao, Zhong-Hua</creator><creator>Zhao, Jiang</creator><creator>Li, Ting</creator><creator>Wu, Zheng-Hua</creator><creator>Zhang, Jin-Feng</creator><creator>Zhang, Jian</creator><creator>Hu, Xi-Chun</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160603</creationdate><title>Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway</title><author>Xie, Jie ; Tao, Zhong-Hua ; Zhao, Jiang ; Li, Ting ; Wu, Zheng-Hua ; Zhang, Jin-Feng ; Zhang, Jian ; Hu, Xi-Chun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-701122c72fb212e6aa273e30d4914e10d369df6cd7ba7631909e08a57cb28b393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Antimetabolites, Antineoplastic - administration & dosage</topic><topic>Apoptosis</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Breast Neoplasms - metabolism</topic><topic>Breast Neoplasms - pathology</topic><topic>Deoxycytidine - administration & dosage</topic><topic>Deoxycytidine - analogs & derivatives</topic><topic>Dose-Response Relationship, Drug</topic><topic>Gemcitabine resistance</topic><topic>GRP78</topic><topic>Heat-Shock Proteins - metabolism</topic><topic>Humans</topic><topic>MCF-7 Cells</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - metabolism</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>Signal Transduction - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xie, Jie</creatorcontrib><creatorcontrib>Tao, Zhong-Hua</creatorcontrib><creatorcontrib>Zhao, Jiang</creatorcontrib><creatorcontrib>Li, Ting</creatorcontrib><creatorcontrib>Wu, Zheng-Hua</creatorcontrib><creatorcontrib>Zhang, Jin-Feng</creatorcontrib><creatorcontrib>Zhang, Jian</creatorcontrib><creatorcontrib>Hu, Xi-Chun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xie, Jie</au><au>Tao, Zhong-Hua</au><au>Zhao, Jiang</au><au>Li, Ting</au><au>Wu, Zheng-Hua</au><au>Zhang, Jin-Feng</au><au>Zhang, Jian</au><au>Hu, Xi-Chun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2016-06-03</date><risdate>2016</risdate><volume>474</volume><issue>3</issue><spage>612</spage><epage>619</epage><pages>612-619</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><abstract>The underlying mechanism of gemcitabine resistance during breast cancer treatment remains unclear. Glucose regulated protein 78 (GRP78) frequently triggered by anticancer agents, was substantially elevated in gemcitabine resistant sublines. Ectopic expression of GRP78 changes gemcitabine chemosensitivity and apoptosis levels in breast cancer cells. Further experiments showed an involvement of caspase 9, not caspase 8, in gemcitabine resistance and GRP78-mediated chemosensitivity, suggesting that mitochondria apoptotic pathway was activated by GRP78. This finding was further supported by the observations of AKT activation, Bcl-2 increase, Bax and Bim decrease. Conclusively, GRP78 plays a vital role in gemcitabine resistance and clinical strategy to improve gemcitabine efficacy in breast cancer by manipulating GRP78 should be explored.
•GRP78 change gemcitabine chemosensitivity and apoptosis by activating Akt/mitochondria apoptotic pathway.•Ectopic expressions of GRP78 change gemcitabine chemosensitivity and apoptosis.•Akt/mitochondria apoptotic pathway, rather than ER stress-induced ER-Ca2+-caspase 8 pathway was activated by GRP78.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27012209</pmid><doi>10.1016/j.bbrc.2016.03.002</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-291X |
ispartof | Biochemical and biophysical research communications, 2016-06, Vol.474 (3), p.612-619 |
issn | 0006-291X 1090-2104 |
language | eng |
recordid | cdi_proquest_miscellaneous_1790461653 |
source | ScienceDirect Journals |
subjects | Antimetabolites, Antineoplastic - administration & dosage Apoptosis Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - metabolism Breast Neoplasms - pathology Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives Dose-Response Relationship, Drug Gemcitabine resistance GRP78 Heat-Shock Proteins - metabolism Humans MCF-7 Cells Mitochondria - drug effects Mitochondria - metabolism Proto-Oncogene Proteins c-akt - metabolism Signal Transduction - drug effects |
title | Glucose regulated protein 78 (GRP78) inhibits apoptosis and attentinutes chemosensitivity of gemcitabine in breast cancer cell via AKT/mitochondrial apoptotic pathway |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A23%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glucose%20regulated%20protein%2078%20(GRP78)%20inhibits%20apoptosis%20and%20attentinutes%20chemosensitivity%20of%20gemcitabine%20in%20breast%20cancer%20cell%20via%20AKT/mitochondrial%20apoptotic%20pathway&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Xie,%20Jie&rft.date=2016-06-03&rft.volume=474&rft.issue=3&rft.spage=612&rft.epage=619&rft.pages=612-619&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2016.03.002&rft_dat=%3Cproquest_cross%3E1790461653%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-701122c72fb212e6aa273e30d4914e10d369df6cd7ba7631909e08a57cb28b393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1790461653&rft_id=info:pmid/27012209&rfr_iscdi=true |